|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00315536 |
|
Date of registration:
|
14/04/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children
|
|
Scientific title:
|
Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children |
|
Date of first enrolment:
|
May 2006 |
|
Target sample size:
|
63 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00315536 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Koen Reyntjens, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital, Ghent |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- ASA I and II children
- 1-6 years
- urological surgery
Exclusion Criteria:
- Cardiac disease
- Diabetes
Age minimum:
1 Year
Age maximum:
6 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Urological Surgery
|
|
Intervention(s)
|
|
Drug: Administration of remifentanil and glycopyrrolate
|
|
Primary Outcome(s)
|
|
Blood pressure
[Time Frame: Twice in 16 minutes.]
|
|
Cardiac index
[Time Frame: Twice in 16 minutes.]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|